Self-managed Abortion (SMA)

Clinical guidance on early pregnancy loss and SMA, safety of outpatient abortion for people with higher body weights, and how to document first-trimester ultrasound findings.

Patient characteristics of IUD placement under sedation, two studies on EC efficacy, substance use and anxiety among patients seeking an abortion, and genital herpes prevalence.

A patient-centered decision aid for tubal sterilization counseling, IUD self-removal experiences, and counseling about pain and medication abortion.

Young people’s concerns about birth control and fertility, expanding EPT and PrEP in the ED, spike in EC demand around the New Year, and abortion decision making.

Highlighting one notable research article from each Research Roundup in 2023.

Continued support for misoprostol-only regimens for medication abortion and self-managed abortion between nine and 16 weeks gestation, the use of home pregnancy tests for follow-up care after a telehealth medication abortion, where adolescents and young adults go online to get abortion information, and disparities in recommended retesting for women with trichomonas vaginalis infections.

Support for safety and efficacy of self-managed misoprostol-only medication abortion, medication abortion information on TikTok, and the impact of the shot and IUDs on vaginal flora.

Management of retained products of conception and a comparison of buccal and vaginal misoprostol for medication abortion, contraceptive values and preferences of adolescents and young adults, and more.